09 01 Base Architecture Lung Small Cell Lung Carcinoma SCLC

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Ionut Alexandru Stefan
DOI: 10.5281/zenodo.18164722
Cited by: 0

Abstract

Small cell lung cancer originates from pulmonary neuroendocrine (Kulchitsky) cells with neuralcrest origin and constitutes 13-15% of all lung cancers [1]. Despite exquisite initial chemosensitivity (60-70% response rates to platinum-etoposide), SCLC exhibits near-universal recurrencewithin 4-6 months, with median overall survival of 9-11 months and 2-year survival

Fields of Study & Subjects

Lung Cancer Research Studies Neuroendocrine Tumor Research Advances Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
6 January 2026
Language
EN